Harpoon Therapeutics, Inc

(NASDAQ:HARP)

Latest On Harpoon Therapeutics, Inc (HARP):

Date/Time Type Description Signal Details
2023-05-11 20:27 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.31 beats by $0.08, revenue of $8.58M beats by $3.77MN/A
2023-04-21 21:04 ESTNewsHarpoon Therapeutics files $250M mixed shelf registrationN/A
2023-03-28 07:03 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.55 misses by $0.08, revenue of $4.1M misses by $2.94MN/A
2023-02-27 15:22 ESTNewsHarpoon Therapeutics (HARP) Presents at SVB Securities Global Biopharma Conference 2023N/A
2022-12-12 14:19 ESTNewsHarpoon adds 122% on updated Phase 1 data for multiple myeloma therapyN/A
2022-11-15 19:48 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.35 beats by $0.20, revenue of $13.6M beats by $7.25MN/A
2022-10-04 17:03 ESTNewsHarpoon Therapeutics appoints Luke Walker as CMON/A
2022-10-04 17:02 ESTNewsAstraZeneca – LogicBio deal indicates more such takeovers are ahead – CantorN/A
2022-09-01 06:10 ESTNewsHarpoon Therapeutics: A Well Undervalued Tri-Specific Oncology PlayerN/A
2022-08-10 17:36 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.53 beats by $0.03, revenue of $8.3M beats by $1.34MN/A
2022-07-08 04:35 ESTNewsHarpoon Therapeutics: A T-Cell Engager Platform And A Negative Enterprise Value Makes It A Candidate For My 'Bio Boom' PortfolioN/A
2022-05-16 12:57 ESTNewsHarpoon stock soars 26% on Wedbush upgrade ahead of HPN328 data in lung cancer at ASCON/A
2022-05-12 18:12 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.62 misses by $0.07, revenue of $5.91M misses by $2.17MN/A
2022-05-02 20:58 ESTNewsRoche and Harpoon strike clinical supply agreement for cancer therapyN/A
2022-04-08 00:28 ESTNewsHarpoon Therapeutics falls as medical chief exitsN/A
2022-03-15 04:13 ESTNewsStreet firms cut price targets on Harpoon Therapeutics, but maintain buy ratingsN/A
2022-03-12 06:41 ESTNewsHarpoon crashes on plans to halt prostate cancer studyN/A
2022-03-11 12:00 ESTNewsHarpoon Therapeutics GAAP EPS of -$0.66 misses by $0.23, revenue of $4.3M misses by $1.9MN/A
2022-03-07 20:36 ESTNewsHarpoon Therapeutics wins FDA’s Orphan Drug Designation for lung cancer therapyN/A
2022-03-02 18:07 ESTNewsHarpoon wins FDA’s Fast Track designation for multiple myeloma therapyN/A
2021-10-26 19:42 ESTNewsHarpoon Therapeutics names board member Julie Eastland as new CEON/A
2021-09-28 17:31 ESTNewsHarpoon Therapeutics, Puma Bio shares gain on Citi upgradeN/A
2021-09-21 20:08 ESTNewsHarpoon Therapeutics (HARP) Investor Presentation - SlideshowN/A
2021-09-21 19:49 ESTNewsHarpoon Therapeutics: A First LookN/A
2021-08-06 04:04 ESTNewsHarpoon Therapeutics EPS misses by $0.09, misses on revenueN/A
2021-07-21 11:03 ESTNewsIterum keeps rising even as RBC analyst cautions, Premier hurt by Barclays’ double downgrade; and more in today’s analyst actionN/A
2021-07-21 10:58 ESTNewsHarpoon shares slide after early-stage prostate cancer study data fails to impressN/A
2021-07-21 10:58 ESTNewsMerus upgraded on ASCO update, Cantor favors Harpoon after selloff; and more in today’s analyst actionN/A
2021-05-07 09:14 ESTNewsHarpoon Therapeutics EPS misses by $1.50, beats on revenueN/A
2021-03-31 02:30 ESTNewsHarpoon Therapeutics: T-Cell Engager Platform For Immune-Related DiseaseN/A
2021-03-12 11:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.67 to $31.22.Neutral
2021-03-12 04:41 ESTNewsHarpoon Therapeutics, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-03-11 19:55 ESTFinancialsCompany financials have been released.Neutral
2021-03-11 11:44 ESTEarnings EstimateAn EPS average of -$0.53 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-11 11:44 ESTEarnings EstimateAn EPS average of -$2.17 is estimated for the 2022 year.Sell
2021-03-11 11:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.89 to $31.67.Neutral
2021-03-11 07:58 ESTNewsHarpoon Therapeutics EPS beats by $0.11, beats on revenueN/A
2021-03-11 07:58 ESTNewsHarpoon Therapeutics, Inc. (HARP) CEO Gerald McMahon on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-13 14:24 ESTNewsHarpoon Therapeutics' HPN217 an orphan drug in U.S. for multiple myelomaN/A
2021-01-07 12:09 ESTNewsHarpoon Therapeutics prices equity offering at $17N/A
2021-01-06 21:19 ESTNewsHarpoon Therapeutics -2.6%, proposes public offeringN/A
2021-01-05 11:55 ESTAnalyst RatingThe Analyst Target Price has increased from $31.56 to $31.89.Buy
2021-01-04 10:22 ESTNewsDosing underway in Harpoon Therapeutics' HPN328 study in small cell lung cancerN/A
2021-01-03 20:04 ESTNewsHarpoon Therapeutics: Potential For Explosive GrowthN/A
2020-12-24 15:59 ESTAnalyst RatingThe Analyst Target Price has increased from $31.22 to $31.56.Buy
2020-12-09 01:02 ESTNewsHarpoon Therapeutics reports partial response from HPN424 early-stage study in prostate cancerN/A
2020-11-26 20:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:01 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 19:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-05 07:59 ESTEarnings EstimateAn EPS average of -$0.49 is estimated for the quarter ending on March 31, 2021.Buy

About Harpoon Therapeutics, Inc (HARP):

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

HARP Quotes by TradingView

See Advanced Chart

General

  • Name Harpoon Therapeutics, Inc
  • Symbol HARP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 78
  • Fiscal Year EndDecember
  • IPO Date2019-02-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.harpoontx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 28.95
  • Price/Book (Most Recent Quarter) 12.14
  • Enterprise Value Revenue 31.02
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.95
  • Next Year EPS Estimate -$2.04
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -286%
  • Operating Margin -294%
  • Return on Assets -18%
  • Return on Equity -67%
  • Revenue 17.44 million
  • Earnings Per Share -$4.05
  • Revenue Per Share $0.7
  • Gross Profit -35121000
  • Quarterly Earnings Growth 235.4%
View More

Highlights

  • Market Capitalization 672.32 million
  • EBITDA -42558000
  • Analyst Target Price $31.22
  • Book Value Per Share $2.11
View More

Share Statistics

  • Shares Outstanding 32.41 million
  • Shares Float 17.65 million
  • % Held by Insiders 1109%
  • % Held by Institutions 79.95%
  • Shares Short 757801
  • Shares Short Prior Month 678029
  • Short Ratio 2.83
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.8
  • 52 Week High $25.24
  • 52 Week Low $10.27
  • 50 Day Moving Average 19.49
  • 200 Day Moving Average 17.2
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Harpoon Therapeutics, Inc (HARP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Harpoon Therapeutics, Inc (HARP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-10$7.49 million-$0.45-$0.5314.5%
2020-09-302020-11-04$N/A-$0.53-$0.51-4.29%
2020-06-302020-08-05$N/A-$0.51-$0.47-8.72%
2020-03-312020-05-06$N/A-$0.51-$0.42-22.13%
2019-12-312020-03-12$2.23 million-$0.58-$0.55-6.31%
2019-09-302019-11-06$1.42 million-$0.65-$0.54-19.35%
2019-06-302019-08-05$1.06 million-$0.49-$0.6321.6%
2019-03-312019-05-09$1.06 million-$0.56-$0.45-24.44%
2018-12-312019-02-08$1.06 million-$8.15-$0.72-1031.94%

Harpoon Therapeutics, Inc (HARP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Harpoon Therapeutics, Inc (HARP) Chart:

Harpoon Therapeutics, Inc (HARP) News:

Below you will find a list of latest news for Harpoon Therapeutics, Inc (HARP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Harpoon Therapeutics, Inc (HARP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest HARP Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST10$2.05
Jun 13, 2022 7:59 PM EST28$2.05
Jun 13, 2022 7:59 PM EST100$2.05
Jun 13, 2022 7:59 PM EST100$2.04
Jun 13, 2022 7:59 PM EST20$2.05

Harpoon Therapeutics, Inc (HARP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120040695/0001209191-20-040695-index.htm
2018-11-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1708493/000000000018035843/0000000000-18-035843-index.htm
2019-02-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1708493/000000000019000638/0000000000-19-000638-index.htm
2020-03-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1708493/000000000020002448/0000000000-20-002448-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000089924319002910/0000899243-19-002910-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000089924319003683/0000899243-19-003683-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000089924319028848/0000899243-19-028848-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000089924319029473/0000899243-19-029473-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000089924320014559/0000899243-20-014559-index.htm
2019-02-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1708493/000094787119000133/0000947871-19-000133-index.htm
2018-10-24DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1708493/000095012318010117/0000950123-18-010117-index.htm
2018-12-12DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1708493/000095012318012342/0000950123-18-012342-index.htm
2018-12-11DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1708493/000095012318012344/0000950123-18-012344-index.htm
2018-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1708493/000119312518359160/0001193125-18-359160-index.htm
2019-01-04S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1708493/000119312519002624/0001193125-19-002624-index.htm
2019-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312519018441/0001193125-19-018441-index.htm
2019-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1708493/000119312519019639/0001193125-19-019639-index.htm
2019-02-04S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1708493/000119312519027138/0001193125-19-027138-index.htm
2019-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312519027184/0001193125-19-027184-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312519027885/0001193125-19-027885-index.htm
2019-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312519027887/0001193125-19-027887-index.htm
2019-02-058-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1708493/000119312519028374/0001193125-19-028374-index.htm
2019-02-08424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1708493/000119312519032439/0001193125-19-032439-index.htm
2019-02-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1708493/000119312519032459/0001193125-19-032459-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312519038191/0001193125-19-038191-index.htm
2019-02-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1708493/000119312519047013/0001193125-19-047013-index.htm
2019-02-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1708493/000119312519048021/0001193125-19-048021-index.htm
2019-02-22SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1708493/000119312519048049/0001193125-19-048049-index.htm
2019-12-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1708493/000119312519311686/0001193125-19-311686-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1708493/000119312520033453/0001193125-20-033453-index.htm
2020-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1708493/000119312520072999/0001193125-20-072999-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1708493/000119312520073017/0001193125-20-073017-index.htm
2020-03-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312520073069/0001193125-20-073069-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520094749/0001193125-20-094749-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520098804/0001193125-20-098804-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1708493/000119312520110768/0001193125-20-110768-index.htm
2020-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1708493/000119312520110786/0001193125-20-110786-index.htm
2020-04-178-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520110801/0001193125-20-110801-index.htm
2020-04-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1708493/000119312520113692/0001193125-20-113692-index.htm
2020-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520155683/0001193125-20-155683-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520157244/0001193125-20-157244-index.htm
2020-06-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1708493/000119312520157363/0001193125-20-157363-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000119312520186045/0001193125-20-186045-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008203/0001209191-19-008203-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008208/0001209191-19-008208-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008210/0001209191-19-008210-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008215/0001209191-19-008215-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008229/0001209191-19-008229-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008239/0001209191-19-008239-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008246/0001209191-19-008246-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008253/0001209191-19-008253-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008256/0001209191-19-008256-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008259/0001209191-19-008259-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008260/0001209191-19-008260-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008264/0001209191-19-008264-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008265/0001209191-19-008265-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008266/0001209191-19-008266-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119008270/0001209191-19-008270-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010288/0001209191-19-010288-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010297/0001209191-19-010297-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010303/0001209191-19-010303-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010306/0001209191-19-010306-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010312/0001209191-19-010312-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010317/0001209191-19-010317-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119010320/0001209191-19-010320-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021729/0001209191-19-021729-index.htm
2019-03-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021730/0001209191-19-021730-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021731/0001209191-19-021731-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021736/0001209191-19-021736-index.htm
2019-03-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021745/0001209191-19-021745-index.htm
2019-03-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119021751/0001209191-19-021751-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119027964/0001209191-19-027964-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119028675/0001209191-19-028675-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119030200/0001209191-19-030200-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034828/0001209191-19-034828-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034836/0001209191-19-034836-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034841/0001209191-19-034841-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034842/0001209191-19-034842-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034844/0001209191-19-034844-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034847/0001209191-19-034847-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119034848/0001209191-19-034848-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119048821/0001209191-19-048821-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119053306/0001209191-19-053306-index.htm
2019-11-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119055169/0001209191-19-055169-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119057167/0001209191-19-057167-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119059085/0001209191-19-059085-index.htm
2019-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119059489/0001209191-19-059489-index.htm
2019-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119059954/0001209191-19-059954-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119061059/0001209191-19-061059-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119061097/0001209191-19-061097-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919119062169/0001209191-19-062169-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120002179/0001209191-20-002179-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120002180/0001209191-20-002180-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120004374/0001209191-20-004374-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120004581/0001209191-20-004581-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120006700/0001209191-20-006700-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120006703/0001209191-20-006703-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120006706/0001209191-20-006706-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120006711/0001209191-20-006711-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120011190/0001209191-20-011190-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120015855/0001209191-20-015855-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120020052/0001209191-20-020052-index.htm
2020-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120022183/0001209191-20-022183-index.htm
2020-04-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120022188/0001209191-20-022188-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120022193/0001209191-20-022193-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120022196/0001209191-20-022196-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120023954/0001209191-20-023954-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120024489/0001209191-20-024489-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120024947/0001209191-20-024947-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120026337/0001209191-20-026337-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120027143/0001209191-20-027143-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120029020/0001209191-20-029020-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120031019/0001209191-20-031019-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033317/0001209191-20-033317-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033318/0001209191-20-033318-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033319/0001209191-20-033319-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033320/0001209191-20-033320-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033321/0001209191-20-033321-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033322/0001209191-20-033322-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120033323/0001209191-20-033323-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120040666/0001209191-20-040666-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120040669/0001209191-20-040669-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120040695/0001209191-20-040695-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120044576/0001209191-20-044576-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120047804/0001209191-20-047804-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000120919120053596/0001209191-20-053596-index.htm
2018-11-26DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000128864918000006/0001288649-18-000006-index.htm
2019-02-06CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1708493/000135445719000060/0001354457-19-000060-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019007819/0001564590-19-007819-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1708493/000156459019007829/0001564590-19-007829-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459019017497/0001564590-19-017497-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019017617/0001564590-19-017617-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019028776/0001564590-19-028776-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459019028819/0001564590-19-028819-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459019041033/0001564590-19-041033-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019041034/0001564590-19-041034-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019044008/0001564590-19-044008-index.htm
2019-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459019046985/0001564590-19-046985-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459020010466/0001564590-20-010466-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1708493/000156459020010479/0001564590-20-010479-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459020021929/0001564590-20-021929-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459020022005/0001564590-20-022005-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459020036816/0001564590-20-036816-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459020036845/0001564590-20-036845-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1708493/000156459020050483/0001564590-20-050483-index.htm
2020-11-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1708493/000156459020050527/0001564590-20-050527-index.htm
2017-06-06DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1708493/000170849317000001/0001708493-17-000001-index.htm
2019-02-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1708493/999999999519000124/9999999995-19-000124-index.htm
2020-04-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1708493/999999999520000841/9999999995-20-000841-index.htm
2019-02-08CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1708493/999999999719000165/9999999997-19-000165-index.htm

Harpoon Therapeutics, Inc (HARP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Harpoon Therapeutics, Inc (HARP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1109%
Institutional Ownership: 7995%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-03Gerald PhD McMahonPresident and CEOBuy1,000.0010.5310,530.001,000.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119027964/0001209191-19-027964-index.htm
2019-06-05Gerald PhD McMahonPresident and CEOBuy169,462.000.60101,677.20172,462.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119048821/0001209191-19-048821-index.htm
2020-07-31Georgia ErbezChief Financial OfficerBuy1,817.0010.9219,841.641,817.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120044576/0001209191-20-044576-index.htm
2019-05-08Gerald PhD McMahonPresident and CEOBuy1,000.0010.5610,558.702,000.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119028675/0001209191-19-028675-index.htm
2020-05-28Bioscience plc Arix10% Share HolderSell366,591.0021.337,820,925.712,193,704.00https://www.sec.gov/Archives/edgar/data/1708493/000089924320014559/0000899243-20-014559-index.htm
2019-02-12New Leaf Ventures III, L.P.10% Share HolderBuy214,286.0014.003,000,004.002,242,839.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010317/0001209191-19-010317-index.htm
2019-02-12RONALD HUNTDirectorBuy214,286.0014.003,000,004.002,242,839.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010306/0001209191-19-010306-index.htm
2020-05-27Bioscience plc Arix10% Share HolderSell12,064.0022.39270,144.332,560,295.00https://www.sec.gov/Archives/edgar/data/1708493/000089924320014559/0000899243-20-014559-index.htm
2019-12-17Bioscience plc Arix10% Share HolderSell12,476.0016.83209,968.582,572,359.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319029473/0000899243-19-029473-index.htm
2019-12-17Mark ChinDirectorSell12,476.0016.83209,968.582,572,359.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119061059/0001209191-19-061059-index.htm
2019-12-16Bioscience plc Arix10% Share HolderSell13,080.0017.02222,680.462,584,835.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319029473/0000899243-19-029473-index.htm
2019-12-16Mark ChinDirectorSell13,080.0017.02222,680.462,584,835.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119061059/0001209191-19-061059-index.htm
2019-12-13Bioscience plc Arix10% Share HolderSell11,002.0017.21189,341.122,597,915.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319029473/0000899243-19-029473-index.htm
2019-12-13Mark ChinDirectorSell11,002.0017.21189,341.122,597,915.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119061059/0001209191-19-061059-index.htm
2019-12-10Bioscience plc Arix10% Share HolderSell131,696.0016.912,227,018.872,608,917.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319028848/0000899243-19-028848-index.htm
2019-12-10Mark ChinDirectorSell131,696.0016.912,227,018.872,608,917.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059954/0001209191-19-059954-index.htm
2019-12-27Patrick BaeuerleDirectorSell1,400.0018.0725,296.60262,136.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119062169/0001209191-19-062169-index.htm
2019-12-27Patrick BaeuerleDirectorSell10,417.0016.90176,061.88263,536.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119062169/0001209191-19-062169-index.htm
2019-12-27Patrick BaeuerleDirectorSell75,562.0015.811,194,922.36273,953.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119062169/0001209191-19-062169-index.htm
2019-12-09Bioscience plc Arix10% Share HolderSell77,316.0018.121,400,664.392,740,613.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319028848/0000899243-19-028848-index.htm
2019-12-09Mark ChinDirectorSell77,316.0018.121,400,664.392,740,613.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059954/0001209191-19-059954-index.htm
2019-12-09Bioscience plc Arix10% Share HolderSell26,438.0018.30483,781.032,817,929.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319028848/0000899243-19-028848-index.htm
2019-12-09Mark ChinDirectorSell26,438.0018.30483,781.032,817,929.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059954/0001209191-19-059954-index.htm
2019-12-06Bioscience plc Arix10% Share HolderSell47,752.0019.15914,221.592,844,367.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319028848/0000899243-19-028848-index.htm
2019-12-06Mark ChinDirectorSell47,752.0019.15914,221.592,844,367.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059954/0001209191-19-059954-index.htm
2019-02-12Bioscience plc Arix10% Share HolderBuy428,571.0014.005,999,994.002,892,119.00https://www.sec.gov/Archives/edgar/data/1708493/000089924319003683/0000899243-19-003683-index.htm
2019-02-12Mark ChinDirectorBuy428,571.0014.005,999,994.002,892,119.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010297/0001209191-19-010297-index.htm
2019-05-14Gerald PhD McMahonPresident and CEOBuy1,000.0010.1610,157.303,000.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119030200/0001209191-19-030200-index.htm
2019-02-12Oncology Impact Fund L.P. UBS10% Share HolderSell447.0014.006,258.003,648,422.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010320/0001209191-19-010320-index.htm
2019-02-12Oncology Impact Fund L.P. UBS10% Share HolderBuy250,000.0014.003,500,000.003,898,422.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010320/0001209191-19-010320-index.htm
2020-08-18Georgia ErbezChief Financial OfficerBuy2,098.0011.6024,336.803,915.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120047804/0001209191-20-047804-index.htm
2019-02-12MPM BioVentures 2014, L.P.10% Share HolderSell1,524.0014.0021,336.004,274,425.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010312/0001209191-19-010312-index.htm
2019-02-12LUKE EVNINDirectorBuy250,000.0014.003,500,000.004,524,425.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010288/0001209191-19-010288-index.htm
2019-02-12MPM BioVentures 2014, L.P.10% Share HolderBuy250,000.0014.003,500,000.004,524,425.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010312/0001209191-19-010312-index.htm
2019-10-14Natalie SacksChief Medical OfficerSell12,452.0013.27165,280.3845,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119053306/0001209191-19-053306-index.htm
2019-10-15Natalie SacksChief Medical OfficerSell11,698.0013.21154,481.4545,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119053306/0001209191-19-053306-index.htm
2019-11-01Natalie SacksChief Medical OfficerSell5,826.0013.1776,701.6245,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119055169/0001209191-19-055169-index.htm
2019-11-18Natalie SacksChief Medical OfficerSell1,000.0014.0014,000.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119057167/0001209191-19-057167-index.htm
2019-12-02Natalie SacksChief Medical OfficerSell5,826.0017.98104,751.4845,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059085/0001209191-19-059085-index.htm
2019-12-16Natalie SacksChief Medical OfficerSell1,521.0017.0225,887.5745,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119061097/0001209191-19-061097-index.htm
2020-01-02Natalie SacksChief Medical OfficerSell5,826.0014.1882,600.4545,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120002179/0001209191-20-002179-index.htm
2020-01-16Natalie SacksChief Medical OfficerSell1,521.0014.9422,724.9645,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120004374/0001209191-20-004374-index.htm
2020-02-03Natalie SacksChief Medical OfficerSell5,826.0013.9081,006.4545,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120006706/0001209191-20-006706-index.htm
2020-02-18Natalie SacksChief Medical OfficerSell1,521.0015.0022,815.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120011190/0001209191-20-011190-index.htm
2020-03-02Natalie SacksChief Medical OfficerSell5,826.0014.6885,525.6845,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120015855/0001209191-20-015855-index.htm
2020-03-16Natalie SacksChief Medical OfficerSell1.0012.0012.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120020052/0001209191-20-020052-index.htm
2020-03-17Natalie SacksChief Medical OfficerSell1,520.0012.0018,240.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120020052/0001209191-20-020052-index.htm
2020-04-06Natalie SacksChief Medical OfficerSell700.0012.008,400.9845,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120023954/0001209191-20-023954-index.htm
2020-04-07Natalie SacksChief Medical OfficerSell570.0012.006,840.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120023954/0001209191-20-023954-index.htm
2020-04-13Natalie SacksChief Medical OfficerSell4,556.0012.0654,959.0345,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024489/0001209191-20-024489-index.htm
2020-04-16Natalie SacksChief Medical OfficerSell500.0012.006,000.0045,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024947/0001209191-20-024947-index.htm
2020-04-17Natalie SacksChief Medical OfficerSell1,021.0012.0812,330.1145,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024947/0001209191-20-024947-index.htm
2020-05-01Natalie SacksChief Medical OfficerSell5,826.0012.0770,301.1845,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120027143/0001209191-20-027143-index.htm
2020-05-18Natalie SacksChief Medical OfficerSell1,522.0014.7722,478.5745,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120031019/0001209191-20-031019-index.htm
2020-03-16Natalie SacksChief Medical OfficerBuy1.002.122.1245,755.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120020052/0001209191-20-020052-index.htm
2020-04-16Natalie SacksChief Medical OfficerBuy500.002.121,060.0046,254.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024947/0001209191-20-024947-index.htm
2020-04-07Natalie SacksChief Medical OfficerBuy570.002.121,208.4046,324.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120023954/0001209191-20-023954-index.htm
2020-04-06Natalie SacksChief Medical OfficerBuy700.002.121,484.0046,454.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120023954/0001209191-20-023954-index.htm
2019-11-18Natalie SacksChief Medical OfficerSell17,252.0013.33229,963.9846,754.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119057167/0001209191-19-057167-index.htm
2020-04-17Natalie SacksChief Medical OfficerBuy1,021.002.122,164.5246,775.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024947/0001209191-20-024947-index.htm
2020-03-17Natalie SacksChief Medical OfficerBuy1,520.002.123,222.4047,274.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120020052/0001209191-20-020052-index.htm
2019-12-16Natalie SacksChief Medical OfficerBuy1,521.002.123,224.5247,275.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119061097/0001209191-19-061097-index.htm
2020-01-16Natalie SacksChief Medical OfficerBuy1,521.002.123,224.5247,275.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120004374/0001209191-20-004374-index.htm
2020-02-18Natalie SacksChief Medical OfficerBuy1,521.002.123,224.5247,275.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120011190/0001209191-20-011190-index.htm
2020-05-18Natalie SacksChief Medical OfficerBuy1,522.002.123,226.6447,276.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120031019/0001209191-20-031019-index.htm
2019-12-04Georgia ErbezChief Financial OfficerBuy47,292.002.12100,259.0447,292.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059489/0001209191-19-059489-index.htm
2020-04-13Natalie SacksChief Medical OfficerBuy4,556.002.129,658.7250,310.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120024489/0001209191-20-024489-index.htm
2019-11-01Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119055169/0001209191-19-055169-index.htm
2019-12-02Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119059085/0001209191-19-059085-index.htm
2020-01-02Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120002179/0001209191-20-002179-index.htm
2020-02-03Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120006706/0001209191-20-006706-index.htm
2020-03-02Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120015855/0001209191-20-015855-index.htm
2020-05-01Natalie SacksChief Medical OfficerBuy5,826.002.1212,351.1251,580.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120027143/0001209191-20-027143-index.htm
2020-01-02Holger WescheChief Scientific OfficerSell10,000.0014.40143,987.0052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120002180/0001209191-20-002180-index.htm
2020-04-28Holger WescheChief Scientific OfficerSell1,250.0014.0517,565.0052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120026337/0001209191-20-026337-index.htm
2020-05-07Holger WescheChief Scientific OfficerSell5,350.0014.1375,575.7152,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-05-08Holger WescheChief Scientific OfficerSell1,000.0014.0014,000.0052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-05-11Holger WescheChief Scientific OfficerSell1,000.0014.0714,065.1052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-05-12Holger WescheChief Scientific OfficerSell1,400.0014.0919,719.9852,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120029020/0001209191-20-029020-index.htm
2020-07-01Holger WescheChief Scientific OfficerSell10,000.0016.20161,989.0052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120040695/0001209191-20-040695-index.htm
2020-10-01Holger WescheChief Scientific OfficerSell1,000.0017.0317,029.9052,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120053596/0001209191-20-053596-index.htm
2020-05-08Holger WescheChief Scientific OfficerBuy1,000.000.60600.0053,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-05-11Holger WescheChief Scientific OfficerBuy1,000.000.60600.0053,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2020-10-01Holger WescheChief Scientific OfficerSell9,000.0016.19145,707.3053,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120053596/0001209191-20-053596-index.htm
2020-04-28Holger WescheChief Scientific OfficerBuy1,250.000.60750.0053,919.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120026337/0001209191-20-026337-index.htm
2020-05-12Holger WescheChief Scientific OfficerBuy1,400.000.60840.0054,069.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120029020/0001209191-20-029020-index.htm
2019-10-15Natalie SacksChief Medical OfficerBuy11,698.002.1224,799.7657,452.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119053306/0001209191-19-053306-index.htm
2020-05-07Holger WescheChief Scientific OfficerBuy5,350.000.603,210.0058,019.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120028407/0001209191-20-028407-index.htm
2019-10-14Natalie SacksChief Medical OfficerBuy12,452.002.1226,398.2458,206.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119053306/0001209191-19-053306-index.htm
2020-01-02Holger WescheChief Scientific OfficerBuy10,000.000.606,000.0062,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120002180/0001209191-20-002180-index.htm
2020-07-01Holger WescheChief Scientific OfficerBuy10,000.000.606,000.0062,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120040695/0001209191-20-040695-index.htm
2020-10-01Holger WescheChief Scientific OfficerBuy10,000.000.606,000.0062,669.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120053596/0001209191-20-053596-index.htm
2019-11-18Natalie SacksChief Medical OfficerBuy18,252.002.1238,694.2464,006.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119057167/0001209191-19-057167-index.htm
2020-01-21Georgia ErbezChief Financial OfficerBuy6,700.0014.0994,417.746,700.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120004581/0001209191-20-004581-index.htm
2019-02-12New Leaf Ventures III, L.P.10% Share HolderBuy214,285.0014.002,999,990.00678,566.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010317/0001209191-19-010317-index.htm
2019-02-12RONALD HUNTDirectorBuy214,285.0014.002,999,990.00678,566.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010306/0001209191-19-010306-index.htm
2019-02-12ANSBERT GADICKE10% Share HolderSell1,971.0014.0027,594.007,922,847.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010303/0001209191-19-010303-index.htm
2019-02-12ANSBERT GADICKE10% Share HolderBuy500,000.0014.007,000,000.008,422,847.00https://www.sec.gov/Archives/edgar/data/1708493/000120919119010303/0001209191-19-010303-index.htm
2020-08-19Georgia ErbezChief Financial OfficerBuy5,000.0011.4057,000.008,915.00https://www.sec.gov/Archives/edgar/data/1708493/000120919120047804/0001209191-20-047804-index.htm